Drugs Activating Glucagon-Like Peptide-1 Receptors May Lower Surgeries and Hospital Visits in Hidradenitis Suppurativa

Patients prescribed glucagon-like peptide-1 receptor agonists had significantly lower rates of surgeries and hospitalizations.

• The hazard ratio for surgeries was 0.35, indicating a substantial reduction in surgical procedures for those receiving glucagon-like peptide-1 receptor agonists.
• Hospitalization rates showed a hazard ratio of 0.87, suggesting a decrease in hospital admissions among these patients.
• These findings indicate a potential anti-inflammatory effect of glucagon-like peptide-1 receptor agonists in managing hidradenitis suppurativa.
• The study used a propensity score-matched cohort to compare outcomes between patients receiving the medication and those who did not.

Simplified